Global Riluzole Tablet Market Growth 2024-2030

Publication ID:

LPI03250161

Publication Date:

March 13, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Riluzole Tablet market size was valued at US$ 39 million in 2023. With growing demand in downstream market, the Riluzole Tablet is forecast to a readjusted size of US$ 36 million by 2030 with a CAGR of -1.3% during review period.
The research report highlights the growth potential of the global Riluzole Tablet market. Riluzole Tablet are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Riluzole Tablet. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Riluzole Tablet market.
Riluzole (marketed as Rilutek, Teglutik and TIGLUTIK) is a drug used to treat amyotrophic lateral sclerosis.
The amyotrophic lateral sclerosis (ALS) therapeutics market is driven by the increasing prevalence of ALS and the growing demand for effective treatments to slow disease progression and improve patient outcomes. As the understanding of ALS pathophysiology improves, researchers and pharmaceutical companies are actively exploring novel therapeutic approaches, including gene therapies and immune-modulating agents. The approval of new ALS drugs and the development of combination therapies further propel market growth. However, challenges include the complexity of ALS as a multi-factorial disease, the difficulty in diagnosing ALS at an early stage, and the high cost of drug development and clinical trials. Addressing these challenges through collaborative research, improved diagnostic tools, and accessible treatment options will be crucial for the sustained growth of the ALS therapeutics market.
Key Features:
The report on Riluzole Tablet market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Riluzole Tablet market. It may include historical data, market segmentation by Type (e.g., With Film-coated, Without Film-coated), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Riluzole Tablet market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Riluzole Tablet market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Riluzole Tablet industry. This include advancements in Riluzole Tablet technology, Riluzole Tablet new entrants, Riluzole Tablet new investment, and other innovations that are shaping the future of Riluzole Tablet.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Riluzole Tablet market. It includes factors influencing customer ' purchasing decisions, preferences for Riluzole Tablet product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Riluzole Tablet market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Riluzole Tablet market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Riluzole Tablet market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Riluzole Tablet industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Riluzole Tablet market.
Market Segmentation:
Riluzole Tablet market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
With Film-coated
Without Film-coated
Segmentation by application
Hospital
Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Italfarmaco
Key Questions Addressed in this Report
What is the 10-year outlook for the global Riluzole Tablet market?
What factors are driving Riluzole Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Riluzole Tablet market opportunities vary by end market size?
How does Riluzole Tablet break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Riluzole Tablet Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Riluzole Tablet by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Riluzole Tablet by Country/Region, 2019, 2023 & 2030
2.2 Riluzole Tablet Segment by Type
2.2.1 With Film-coated
2.2.2 Without Film-coated
2.3 Riluzole Tablet Sales by Type
2.3.1 Global Riluzole Tablet Sales Market Share by Type (2019-2024)
2.3.2 Global Riluzole Tablet Revenue and Market Share by Type (2019-2024)
2.3.3 Global Riluzole Tablet Sale Price by Type (2019-2024)
2.4 Riluzole Tablet Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Riluzole Tablet Sales by Application
2.5.1 Global Riluzole Tablet Sale Market Share by Application (2019-2024)
2.5.2 Global Riluzole Tablet Revenue and Market Share by Application (2019-2024)
2.5.3 Global Riluzole Tablet Sale Price by Application (2019-2024)
3 Global Riluzole Tablet by Company
3.1 Global Riluzole Tablet Breakdown Data by Company
3.1.1 Global Riluzole Tablet Annual Sales by Company (2019-2024)
3.1.2 Global Riluzole Tablet Sales Market Share by Company (2019-2024)
3.2 Global Riluzole Tablet Annual Revenue by Company (2019-2024)
3.2.1 Global Riluzole Tablet Revenue by Company (2019-2024)
3.2.2 Global Riluzole Tablet Revenue Market Share by Company (2019-2024)
3.3 Global Riluzole Tablet Sale Price by Company
3.4 Key Manufacturers Riluzole Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Riluzole Tablet Product Location Distribution
3.4.2 Players Riluzole Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Riluzole Tablet by Geographic Region
4.1 World Historic Riluzole Tablet Market Size by Geographic Region (2019-2024)
4.1.1 Global Riluzole Tablet Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Riluzole Tablet Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Riluzole Tablet Market Size by Country/Region (2019-2024)
4.2.1 Global Riluzole Tablet Annual Sales by Country/Region (2019-2024)
4.2.2 Global Riluzole Tablet Annual Revenue by Country/Region (2019-2024)
4.3 Americas Riluzole Tablet Sales Growth
4.4 APAC Riluzole Tablet Sales Growth
4.5 Europe Riluzole Tablet Sales Growth
4.6 Middle East & Africa Riluzole Tablet Sales Growth
5 Americas
5.1 Americas Riluzole Tablet Sales by Country
5.1.1 Americas Riluzole Tablet Sales by Country (2019-2024)
5.1.2 Americas Riluzole Tablet Revenue by Country (2019-2024)
5.2 Americas Riluzole Tablet Sales by Type
5.3 Americas Riluzole Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Riluzole Tablet Sales by Region
6.1.1 APAC Riluzole Tablet Sales by Region (2019-2024)
6.1.2 APAC Riluzole Tablet Revenue by Region (2019-2024)
6.2 APAC Riluzole Tablet Sales by Type
6.3 APAC Riluzole Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Riluzole Tablet by Country
7.1.1 Europe Riluzole Tablet Sales by Country (2019-2024)
7.1.2 Europe Riluzole Tablet Revenue by Country (2019-2024)
7.2 Europe Riluzole Tablet Sales by Type
7.3 Europe Riluzole Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Riluzole Tablet by Country
8.1.1 Middle East & Africa Riluzole Tablet Sales by Country (2019-2024)
8.1.2 Middle East & Africa Riluzole Tablet Revenue by Country (2019-2024)
8.2 Middle East & Africa Riluzole Tablet Sales by Type
8.3 Middle East & Africa Riluzole Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Riluzole Tablet
10.3 Manufacturing Process Analysis of Riluzole Tablet
10.4 Industry Chain Structure of Riluzole Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Riluzole Tablet Distributors
11.3 Riluzole Tablet Customer
12 World Forecast Review for Riluzole Tablet by Geographic Region
12.1 Global Riluzole Tablet Market Size Forecast by Region
12.1.1 Global Riluzole Tablet Forecast by Region (2025-2030)
12.1.2 Global Riluzole Tablet Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Riluzole Tablet Forecast by Type
12.7 Global Riluzole Tablet Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Riluzole Tablet Product Portfolios and Specifications
13.1.3 Sanofi Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Mylan Pharma
13.2.1 Mylan Pharma Company Information
13.2.2 Mylan Pharma Riluzole Tablet Product Portfolios and Specifications
13.2.3 Mylan Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Mylan Pharma Main Business Overview
13.2.5 Mylan Pharma Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Riluzole Tablet Product Portfolios and Specifications
13.3.3 Apotex Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Glemark Generics
13.4.1 Glemark Generics Company Information
13.4.2 Glemark Generics Riluzole Tablet Product Portfolios and Specifications
13.4.3 Glemark Generics Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Glemark Generics Main Business Overview
13.4.5 Glemark Generics Latest Developments
13.5 Covis Pharma
13.5.1 Covis Pharma Company Information
13.5.2 Covis Pharma Riluzole Tablet Product Portfolios and Specifications
13.5.3 Covis Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Covis Pharma Main Business Overview
13.5.5 Covis Pharma Latest Developments
13.6 Sun Pharma
13.6.1 Sun Pharma Company Information
13.6.2 Sun Pharma Riluzole Tablet Product Portfolios and Specifications
13.6.3 Sun Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sun Pharma Main Business Overview
13.6.5 Sun Pharma Latest Developments
13.7 Lunan Pharma
13.7.1 Lunan Pharma Company Information
13.7.2 Lunan Pharma Riluzole Tablet Product Portfolios and Specifications
13.7.3 Lunan Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lunan Pharma Main Business Overview
13.7.5 Lunan Pharma Latest Developments
13.8 Italfarmaco
13.8.1 Italfarmaco Company Information
13.8.2 Italfarmaco Riluzole Tablet Product Portfolios and Specifications
13.8.3 Italfarmaco Riluzole Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Italfarmaco Main Business Overview
13.8.5 Italfarmaco Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂